Insulin glargine and lixisenatide Subcutaneous and Promacta (Eltrombopag Tablets)
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Promacta (Eltrombopag Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: eltrombopag
Brand name: Promacta
Synonyms: Promacta
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Promethazine
- Insulin glargine and lixisenatide Subcutaneous-Promethazine and Phenylephrine
- Insulin glargine and lixisenatide Subcutaneous-Promethazine Hydrochloride
- Insulin glargine and lixisenatide Subcutaneous-Promethazine injection
- Insulin glargine and lixisenatide Subcutaneous-Promethazine Injection, Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Promethazine rectal
- Promacta (Eltrombopag Tablets)-Insulin glargine, recombinant Subcutaneous
- Promacta (Eltrombopag Tablets)-Insulin glulisine
- Promacta (Eltrombopag Tablets)-Insulin Glulisine (Cartridges and Pens)
- Promacta (Eltrombopag Tablets)-Insulin Glulisine (Vials)
- Promacta (Eltrombopag Tablets)-Insulin glulisine Subcutaneous
- Promacta (Eltrombopag Tablets)-Insulin human inhaled Inhalation